Test Price
2,800 AED✅ Home Collection Available
OSMR Gene (Primary Localized Cutaneous Amyloidosis Type 1) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين OSMR (الداء النشواني الجلدي الموضع الأولي من النوع الأول) بتقنية التسلسل الجيني الفائق في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
ملخص تنفيذي:
يوفر هذا الاختبار تحليلاً جينياً دقيقاً لجين OSMR باستخدام تقنية التسلسل الجيني الفائق (NGS) بدقة تشخيصية 99.9%، تحت إشراف مختبر معتمد من هيئة الصحة بدبي، مع خدمة سحب منزلي فاخرة واستشارة سريرية ما بعد الفحص.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Overview
This advanced NGS panel sequences the entire OSMR gene to detect mutations linked to primary localized cutaneous amyloidosis type 1, a rare dermatological condition. Our test utilizes high‑depth Illumina sequencing, ensuring comprehensive coverage and variant classification per ACMG guidelines, ideal for dermatologists, oncologists, and genetic counsellors seeking confirmation of hereditary cutaneous amyloidosis.
| Feature | Our Test (NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Methodology | Next‑Generation Sequencing (Illumina) | Limited hotspot Sanger sequencing |
| Precision | >99.9% analytical sensitivity for all exons | 90‑95% in covered regions only |
| Speed | 3‑4 Weeks | 6‑8 Weeks |
Physician Insight & Safety Protocol
“As a dermatologist and genetic medicine specialist, I understand that pursuing genetic testing for a rare amyloidosis can be emotionally challenging. This test provides valuable insights into your genetic makeup, but results must always be interpreted alongside clinical findings and family history. I encourage you to discuss the outcomes with a qualified genetic counselor to fully understand the implications.”
— Dr. Prabhakar Reddy, DHA License No. 61713011
Medication Warning: Do not discontinue prescribed medication without consulting your doctor.
Exclusion Criteria & ER Red Flags
- Age restriction: Minors require legal guardian consent as per UAE CDS Law 2026.
- Sample collection: Active dermatological infection at blood draw site or known severe coagulopathy prevents standard venipuncture.
- Emergency signs: Seek immediate medical attention if you experience weight loss, macroglossia, cardiac arrhythmias, or nephrotic syndrome – these may suggest systemic amyloidosis.
- Not for acute diagnosis: This genetic test does not replace urgent clinical evaluation.
Patient FAQ & Clinical Guidance
1. What is the purpose of this OSMR gene test?
This NGS test identifies mutations in OSMR causing primary localized cutaneous amyloidosis type 1, enabling precise diagnosis and family risk assessment. يحدد هذا الاختبار بدقة الطفرات الجينية في جين OSMR المرتبطة بالداء النشواني الجلدي الموضع الأولي من النوع الأول، مما يساعد في التشخيص وتقييم المخاطر العائلية.
2. How is the test performed and what samples are accepted?
A simple blood draw, extracted DNA, or a dried blood spot on an FTA card is sufficient for high‑quality DNA extraction. يكفي مجرد سحب عينة دم بسيطة، أو حمض نووي مستخلص، أو بقعة دم جافة على بطاقة FTA لإجراء استخراج عالي الجودة للحمض النووي.
3. Is genetic counseling included with the test?
We strongly recommend pre‑test genetic counseling to draw a family pedigree; post‑test telephonic clinical guidance is provided to interpret results. نوصي بشدة بجلسة استشارة وراثية قبل الفحص لرسم شجرة العائلة، كما نقدم توجيهًا سريريًا هاتفيًا بعد الفحص لتفسير النتائج.
Pre‑ Information:
A genetic counselling session to draw a pedigree chart of family members affected with OSMR gene amyloidosis is advised. Provide a detailed clinical history of the patient. No specific drug or supplement avoidance is required; continue all prescribed medications unless otherwise directed by your physician.
Compliant with Federal Decree‑Law No. 41 of 2024 (Art. 87), UAE CDS Law 2026 (Minors), and UAE PDPL. Laboratory accredited to ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). All data handled per UAE privacy regulations.
Contact & WhatsApp Support: +971 54 548 8731 | DHA Facility License: 9834453
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians